Meeder Asset Management’s Twist Bioscience TWST Stock Holding History

Meeder Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$162K	Buy	+1,571	New	+$102K	0.01%	320
2023 Q2	–	Sell	-1,262	Closed	-$19K	–	607
2023 Q1	$19K	Sell	1,262 -64,628	-98%	-$1.43M	﹤0.01%	482
2022 Q4	$1.57M	Buy	65,890 +65,672	+30,125%	+$1.9M	0.14%	155
2022 Q3	$8K	Buy	218 +181	+489%	+$7.69K	﹤0.01%	1427
2022 Q2	$1K	Buy	+37	New	+$1.31K	﹤0.01%	2083
2021 Q4	–	Sell	-3,294	Closed	-$352K	–	2267
2021 Q3	$352K	Sell	3,294 -37	-1%	-$4.24K	0.02%	571
2021 Q2	$444K	Buy	3,331 +1,059	+47%	+$123K	0.02%	542
2021 Q1	$282K	Buy	+2,272	New	+$345K	0.01%	648
2020 Q4	–	Sell	-1,131	Closed	-$87K	–	2225
2020 Q3	$87K	Buy	1,131 +934	+474%	+$58.2K	0.01%	825
2020 Q2	$9K	Sell	197 -1,200	-86%	-$43.1K	﹤0.01%	1362
2020 Q1	$43K	Buy	+1,397	New	+$37.6K	﹤0.01%	967

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Meeder Asset Management's TWST Position: Q2 2026 in Review

Meeder Asset Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 1,571 shares worth $162K. The stake represents 0.01% of the portfolio and ranks #320 among its holdings. This is a return to the name: Meeder Asset Management previously reported a position in TWST as recently as Q1 2023.

Meeder Asset Management first reported a position in TWST in Q1 2020 and has held it in 11 quarters since. The position peaked at $1.57M in Q4 2022. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Meeder Asset Management held 1,571 shares of Twist Bioscience worth $162K as of Q2 2026.
Twist Bioscience was a new Meeder Asset Management position in Q2 2026.
Twist Bioscience made up 0.01% of Meeder Asset Management's portfolio in Q2 2026, its #320 holding.
Meeder Asset Management first reported a position in Twist Bioscience in Q1 2020 and has held it in 11 quarters since.
Meeder Asset Management's Twist Bioscience position peaked at $1.57M in Q4 2022.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.